Virtual clinical trials, also known as decentralised clinical trials or remote clinical trials, are a new approach to clinical research in which some or all of the trial procedures are carried out remotely using digital technologies and decentralised methodologies. This implies that participants can take part in the trial from the comfort of their own homes or other convenient locations, providing data, interacting with healthcare providers, and participating in study-related activities using digital devices and platforms.

According to SPER market research, ‘Global Virtual Clinical Trials Market Growth, Size, Trends Analysis - By Study Design, By Indication, By Phase - Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Virtual Clinical Trials Market is predicted to reach 16.52 billion by 2034 with a CAGR of 5.95%.

Drivers:

Factors contributing to market expansion include the deployment of remote monitoring technologies, an increase in R&D efforts, and more healthcare digitisation. As more pharmaceutical companies, contract research organisations (CROs), and research institutions recognise the benefits of virtual trials provided by remote monitoring technologies, there is an increasing demand for solutions and services that facilitate their deployment. In addition, firms specialising in wearable devices, mobile health applications, and telemedicine platforms are developing and selling revolutionary solutions customised exclusively for virtual clinical trials, expanding the market.

Request a Free Sample Report: https://www.sperresearch.com/report-store/virtual-clinical-trials-market?sample=1

Restraints:

The rigorous laws and regulations are projected to stifle expansion in the worldwide virtual clinical trials market. The challenges and complexity associated with virtual clinical trials are another factor preventing the sector from expanding. There are various hurdles to virtual clinical trials, including data protection, regulatory compliance, and standard operating procedures. The privacy of patient data is a key problem. Furthermore, the amount of data created by virtual trials requires more time for analysis, and clinical trials conducted in an unsterile environment may result in illness and discrepancies when compared to medical sites.

North America held the largest revenue share in 2024 and is expected to maintain its lead due to increased research and development, adoption of new technologies in clinical research, and government support. Companies are also using digital technologies to meet client needs. Some of the key market players are ICON, plc, Parexel International Corporation, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, and others.

For More Information, refer to below link: –  

Virtual Clinical Trials Market Share

 Related Reports:  

Hydrotherapy Equipment Market Growth

Peptide and Oligonucleotide CDMO Market

Follow Us – 

LinkedIn | Instagram | Facebook | Twitter 

Contact Us: 

Sara Lopes, Business Consultant — USA 

SPER Market Research 

enquiries@sperresearch.com 

+1–347–460–2899